Preoperative autologous donation

Transfusion

Volumn 36, Issue 7, 1996, Pages 633-639

  Thomas, M J G ^a   Gillon, J ^a   Desmond, M J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD STORAGE; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; PATIENT SELECTION; PHLEBOTOMY; PREGNANCY; PREOPERATIVE PERIOD; ADULT; AGED; BLOOD; BLOOD BANK; CHILD; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG CONTRAINDICATION; ECONOMICS; FEMALE; HEART DISEASE; HUMAN; INFECTION CONTROL; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PREGNANCY COMPLICATION; PREOPERATIVE CARE; REVIEW; STANDARD;

ADULT; AGED; BLOOD BANKS; BLOOD TRANSFUSION, AUTOLOGOUS; CHILD; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; ERYTHROPOIETIN; FEMALE; HEART DISEASES; HUMANS; INFECTION CONTROL; PATIENT SELECTION; PREGNANCY; PREGNANCY COMPLICATIONS; PREOPERATIVE CARE;

EID: 0030191684     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36796323063.x     Document Type: Conference Paper

References (94)

1. Guidelines for autologous transfusion. I. Pre-operative autologous donation. BCSH Transfusion Task Force. Transfusion Med 1993;3:307-16.
2. Widmann FK, ed. Standards for blood banks and transfusion services. 15th ed. Bethesda: American Association of Blood Banks, 1993.
3. Guidelines for autologous blood transfusion. Vox Sang 1989;57:278-80.
4. DePalma L, Luban NLC. Autologous Blood Transfusion in Pediatrics. Pediatrics 1990;85:125-8.
5. McVay PA, Andrews A, Hoag MS, et al. Moderate and severe reactions during autologous blood donations are no more frequent than during homologous blood donations. Vox Sang 1990;59:70-2.
6. McVay PA, Andrews A, Kaplan EB, et al. Donation reactions among autologous donors. Transfusion 1990;30:249-52..PA
7. Zuck TF and Carey PM. Autologous transfusion practice, controversies about current fashions and real needs. Vox Sang 1990;58:234-53.
8. Dzik WH, Devarajan S. Should autologous blood that tests positive for infectious diseases be used or discarded? A decision analysis approach. Transfusion 1989;29:743-5
9. Howard MR, Chapman CE, Dunstan JA, et al. Regional transfusion centre preoperative blood donation programme: the first two years. BMJ 1992;305:1470-3.
10. Goodnough LT, Vizmeg K, Verbrugge D. The impact of autologous blood ordering and blood procurement practices on allogeneic blood exposure in elective orthopedic surgery patients. Amer J Clin Path 1994;101:354-7.
11. Toy PTCY, Menozzi D, Strauss RG, et al. Efficacy of preoperative donation of blood for autologous use in radical prostatectomy. Transfusion 1993;33:721-4.
12. Thomson JD, Callaghan JJ, Savory CG, et al. Prior deposition of autologous blood in elective orthopaedic surgery. J Bone Jt Surg 1987;69A:320-4.
13. Toy PTCY, Strauss RG, Stehling LC, et al. Predeposited autologous blood for elective surgery; a national multicenter study. N Engl J Med 1987;316:517-20.
14. Toy PTCY, McVay PA, Strauss RG, et al. Improvement in appropriate autologous donations with local education. Transfusion 1992;32(6):562-4.
15. Giblett ER. Blood Group alloantibodies: An assessment of some laboratory practices. Transfusion 1977;17:299.
16. Herbert WNP, Owen HG, Collins ML. Autologous blood storage in obstetrics. Obstet Gynecol 1988;72:166-70.
17. Stehling L. The surgical patient transfusion management. In: Wilson SM, Levitt JS, Strauss RG eds. Improving transfusion practice for pediatric patients. Arlington: American Association of Blood Banks, 1991:44-69.
18. Yomtovian R. Pediatric autologous blood transfusion utility and options. AABB News Briefs 1989;11:8.
19. Tasaki T, Ohio H, Noguchi M, et al. Autologous blood donation elective surgery in children. Vox Sang 1994;66:188-93.
20. Goodnough LT, Vizmeg K, Sobecks R, et al. Prevalence and classification of anemia in elective orthopedic surgery patients: implications for blood conservation programs. Vox Sang 1992;63:90-5.
21. Goodnough LT, Wasman J, Corlucci K, Chernosky A. Limitations to donating adequate autologous blood prior to elective orthopedic surgery. Arch Surg 1989;124:494-6.
22. Zanjani ED, Ascensao JL. Erythropoietin. Transfusion 1989;29:46-57.
23. Goodnough LT, Rudnick S, Price TH, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989;321:1163-8.
24. Helm RE, Gold JP, Rosengart TK, et al. Erythropoietin in cardiac surgery. J Card Surg 1993;8:579-606.
25. Mercuriali F, Adamson J. Recombinant human erythropoietin enhances blood donation for autologous use and reduces exposure to homologous blood during elective surgery. Semin Hematol 1993;30(Suppl 6):17-21.
26. Beris P, Mermillod B, Levy G, et al. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. Vox Sang 1993;65:212-8.
27. Hayashi J, Kumon K, Taknashi S, et al. Subcutaneous administration of recombinant human erythropoietin before cardiac surgery: a double-blind, multicenter trial in Japan. Transfusion 1994;34:142-6.
28. Mercuriali F, Zanella A, Barosi G, et al. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993;33:55-60.
29. Mercuriali F, Gualtieri G, Sinigaglia L, et al. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery. Transfusion 1994;34:501-6.
30. Tasaki T, Ohto H, Noguchi M, et al. Iron and erythropoietin measurement in autologous blood donors with anemia: implications for management. Transfusion 1994;34:337-43.
31. Spivak JL. Recombinant human erythropoietin and its role in transfusion medicine. Transfusion 1994;34:1-4.
32. Goodnough LT, Price T, Parvin C, et al. Erythropoietin response to anaemia is not altered by surgery or recombinant human erythropoietin therapy. Brit J Haem 1994;87:695-9.
33. Canadian Erythropoietin Study Group. Association between human recombinant erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br Med J 1990;300:573-8.
34. Eschback JW, Abdulhadi MH, Brown JK, et al. Recombinant human erythropoietin in anaemic individuals with end-stage renal disease: Results of a phase III multicenter clinical trial. Ann Thorac Surg 1989;11:992-1000.
35. Klingermann HG, Shepard JD, Eaves CJ, et al. The role of erythropoietin and other growth factors in transfusion medicine. Transf Med Rev 1991;5:33-47.
36. Raine AEG, Roger SD. Effects of erythropoietin on blood pressure. Am J Kidney Dis 1991;18(Suppl):76-83.
37. Gillon J, Bell K, Prescott RJ. Autologous transfusion - too far, too soon? Vox Sang 1991;61:81-3.
38. Goodnough LT, Price TH, Friedman KD, et al. A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion 1994;34:66-71.
39. Richards C, Kolins J, Trindade CD. Autologous transfusion-transmitted Yersinia enterocolitica. JAMA 1992;268:1541-2.
40. AuBuchon JP, Popovsky MA. The safety of preoperative autologous blood donation in the non-hospital setting. Transfusion 1991;31:513-7.
41. Goodnough LT. Autologous transfusion: Scope and liabilities. Monograph (in press).
42. Goodnough LT, Monk TG. Evolving concepts in autologous blood procurement and transfusion: a report of three patients with acomplication of myocardial infarction in a setting of perisurgical anemia. Am J Surg (in press).
43. Schmidt PJ. Blood donation by the healthy elderly. Transfusion 1991;31:681-3.
44. Haugen RK, Hill GE. A large-scale autologous blood program in a community hospital - a contribution to the community's blood supply. JAMA 1987;257:1211-4.
45. Spiess BD, Sassetti R, McCarthy RJ, et al. Autologous blood donation: hemodynamics in a high risk patient population. Transfusion 1992;32:17-22
46. Gibson J, Zapparo L. Autologous predeposit blood donation in pregnancy - a perspective. Aust NZ J Obstet Gynaecol 1993;33:276-9.
47. Sassetti R, Spiess B, Naebone R. Hemodynamic changes in high-risk autologous donors (abstract). Transfusion 1988;28(Suppl):345.
48. Van Dyck MJ, Baele PL, Leclercq BS, et al. Autologous blood donation before myocardial revascularisation: a Holter-electrocardiographic analysis. J Cardiothor Vasc Anesth 1994;8:162-7.
49. Kruger LM, Colbert JM. Intraoperative autologous transfusion in children undergoing spinal surgery. J Ped Orthop 1985;5:330-2.
50. Mann M, Sacks HJ, Goldfinger D. Safety of autologous blood donations prior to elective surgery for a variety of potentially (high-risk) patients. Transfusion 1983;23:229-32.
51. Cowell HR, Swickard JW. Autotransfusion in children's orthopedics. J Bone Joint Surg (Am) 1974;56:908-12.
52. Silvergleid AJ. Safety and effectiveness of predeposit autologous transfusion in preteen and adolescent children. JAMA 1987;257:3403-4.
53. Novak RW. Autologous blood transfusion in a pediatric population. Clin Ped 1988;27:184-7.
54. Nonoguchi H, Sato T, Tomiyama H, et al. Autologous blood donation and vaso-vagal reactions. Lancet 1993;341:1025-6.
55. Kruskall MS, Leonard S, Klapholz H. Autologous blood donations during pregnancy: analysis of safety and blood use. Obstet Gynaecol 1987;70:938-41.
56. McVay PA, Hoag RW, Hoag MS, et al. Safety and use of autologous blood donation during the third trimester of pregnancy. Am J Obstset Gynecol 1989;160:1479-88.
57. Tabor E. Potential risks of blood donation during pregnancy for autologous transfusion. Transfusion. 1990;30:76.
58. Linden JV. Autologous blood errors and incidents. ISBT Abstracts 1994.
59. McClelland DBL, Phillips P. Errors in blood transfusion in Britain: survey of hospital haematology departments. BMJ 1994;308:1205-6.
60. Renner SW, Howanitz PJ, Bachner P. Preoperative autologous blood donation in 612 hospitals. Arch Pathol Lab Med 1992;116:613-9.
61. Simpson MB, Georgopoulos G, Orsini E, et al. Autologous transfusions for orthopaedic procedures at Children's Hospital. J Bone Joint Surg (Am) 1992;74:652-8.
62. Skettino S, Ferguson K, Andrews A, et al. Donor room personnel attitudes toward autologous donors. Transfusion 1991;31:249-53
63. Kay LA. Predeposit autologous blood transfusion, logistics and costs in the public and private sector in Britain. Haematology Rev 1992;7:17-25.
64. Goodnough LT, Bodner MS, Martin JW. Blood transfusion and blood conservation: cost and utilisation issues. Am J Med Qual 1994;9:172-83.
65. Kruskall MS, Yomtovian R, Dzik WH, et al. On improving the cost effectiveness of autologous blood transfusion practices. Transfusion 1994;34:259-64.
66. Friedman BA, Oberman HA, Chadwick AR, Kingdon K. The maximum surgical blood order schedule and surgical blood use in United States. Transfusion 1976;17:163-8.
67. Toy P, Hoag S, Lamberson HV, et al, and the Preoperative Autologous Blood Donation Study Group. Higher non-A, non-B hepatitis surrogate marker rates in designated donor units (abstract). Transfusion 1988;28(Suppl):175.
68. Timoteo R, Grunenberg R, Bloedorn H, Kruger J. Eignungsvergleich von Erst-und Verwandtenspendern. Beitr Infusionther 1990;26:267-9.
69. Starkey JM, MacPherson JL, Bolgiano DC, et al. Markers for transfusion transmitted disease in different groups of blood donors. JAMA 1989;24:3452-4.
70. Linden JV, Kaplan HS. Transfusion errors: causes and effects. Trans Med Rev 1994;8:169-83.
71. Linden JV, Paul B, Dressler KP. Report of 104 transfusion errors in New York State. Transfusion 1992;32:601-6.
72. Wenz B, Burns ER. Improvement in transfusion safety using a new blood unit and patient identification system as part of safe transfusion practice. Transfusion 1991;31:401-3.
73. AuBuchon JP, Littenberg B. Cost-effectiveness of a barrier system to prevent mistransfusion. Vox Sang 1994;67(Suppl 2):80.
74. Wallace EL, Surgenor DM, Hao HS, et al. Collection and transfusion of blood and blood components in the United States, 1989. Transfusion 1993;33:139-44.
75. Moore SB, Swenke PK, Foss ML, et al. Simplified enrollment for autologous transfusion: automatic referral of presurgical patients for assessment for autologous blood collections. Mayo Clin Proc 1992;67:323-7.
76. Pinkerton PH, Coovadia AS. A Canadian hospital-based autologous program; experience with 4 surgical procedures. ISBT Abstracts 1994.
77. Owings DV, Kruskall MS, Thurer RL, et al. Autologous blood donation prior to elective cardiac surgery - safety and effect on subsequent blood use. JAMA 1989;262:1963-8.
78. Gravlee GP. Con: autologous blood collection is not useful for elective coronary artery bypass graft surgery. J Cardiothor Vasc Anesth 1994;8:238-41.
79. AuBuchon JP, Gettinger A, Littenberg B. Determinants of physician ordering of preoperative autologous donations. Vox Sang 1994;66:176-81.
80. Bird AR, Heyns A DuP. Frozen stored red cells and autologous transfusion. SAMJ 1993;83:308-9.
81. Thomas MJG. Military experience in blood supply applicable to disaster medicine. In: Castelli D, Genetet B, Habibi B, Nydegger U eds. Transfusion in europe. Paris; Arnette SA, 1990:237-8.
82. Goodnough LT. The implications of cost-effectiveness for autologous blood procurement. Arch Pathol Lab Med 1994;118:333-4.
83. Birkmeyer D, AuBuchon P, Littenberg B, et al. Effectiveness of preoperative autologous blood donation in coronary artery bypass grafting. Ann Thorac Surg 1994;57:161-9.
84. Adegboyega PA. The implications of cost-effectivness for autologous blood procurement. Arch Pathol Lab Med 1994;118:1168.
85. Bell K, Gillon J. Erythropoietin and preoperative blood donation. N Engl J Med 1990;322:1158.
86. Goodnough LT. Autologous blood donation. JAMA 1988;259:2405.
87. Goodnough LT. Clinical application of recombinant erythropoietin in the perioperative period. Hemat Oncol Clinics N Am 1994;8:1011-20.
88. Goodnough LT. Cost-effective strategies for autologous blood procurement before surgery. ISBT Abstracts 1994.
89. Blumberg N, Kirkley SA, Heal JM. A cost analysis of autologous and allogeneic transfusions in hip replacement surgery. Am J Surg (in press).
90. Spiess BD. Pro: Autologous blood should be available for elective cardiac surgery. J Cardiothor Vasc Anesth 1994;8:231-7.
91. AuBuchon JP, Birkmeyer JD. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost? Transfusion 1994;34:79-83.
92. AuBuchon JP. Minimizing donor exposure in hemotherapy. Arch Pathol Lab Med 1994;118:380-91.
93. Etchason J, Petz L, Keeler E, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995;332:719-24.
94. Rutherford CJ, Kaplan HS. Autologous blood donation - can we bank on it? N Engl J Med 1995;332:740-2.